AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/3011% below fair value
$11.49−0.29 (-2.46%)
Close on Nov 17, 2026Market cap $483.21MP/E –Yield –
AngioDynamics net income
Net income is the profit left for shareholders after every expense, interest and tax.
AngioDynamics's net income for the twelve months ending Aug 31, 2026 was -$32.94M. For fiscal 2026 it was -$36.74M. The highest annual figure on record is $61.34M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$36.74M | – |
| FY2025 | May 31, 2025 | -$33.99M | – |
| FY2024 | May 31, 2024 | -$184.35M | – |
| FY2023 | May 31, 2023 | -$52.44M | – |
| FY2022 | May 31, 2022 | -$26.55M | – |
| FY2021 | May 31, 2021 | -$31.55M | – |
| FY2020 | May 31, 2020 | -$166.79M | -371.9% |
| FY2019 | May 31, 2019 | $61.34M | +275.5% |
| FY2018 | May 31, 2018 | $16.34M | +226.2% |
| FY2017 | May 31, 2017 | $5.01M | – |
| FY2016 | May 31, 2016 | -$43.59M | – |
| FY2015 | May 31, 2015 | -$3.39M | -244.4% |
| FY2014 | May 31, 2014 | $2.35M | – |
| FY2013 | May 31, 2013 | -$1.05M | – |
| FY2012 | May 31, 2012 | -$5.33M | -166.0% |
| FY2011 | May 31, 2011 | $8.08M | -34.4% |
| FY2010 | May 31, 2010 | $12.31M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$7.10M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$11.41M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$8.08M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$6.35M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$10.90M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$6.05M | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$4.41M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$10.74M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$12.80M | -127.9% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$13.45M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$187.74M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$29.05M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $45.88M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -$21.47M | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$9.49M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$8.49M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$13.00M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$13.00M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$4.96M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$8.35M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$6.97M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$19.47M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$3.54M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -$4.27M | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$4.27M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$157.07M | -366.8% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$5.71M | -817.2% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$2.74M | -227.9% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$1.28M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $58.87M | +2700.8% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $796.00K | -94.3% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $2.14M | +759.4% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$469.00K | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $2.10M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $14.02M | +385.6% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $249.00K | -98.2% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$35.00K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$12.91M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $2.89M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $13.73M | – |
See a number that looks wrong?